“…16,38,39 In the 1980s we strove for high urgency transplantation immediately after VAD implantation. With increased understanding of shock pathophysiology and improvements in VAD technology leading to a subsequent decrease in the complication rates (e.g., bleeding and thromboembolism), 35,40,41 and, more importantly, having seen a number of donor organs wasted in recipients with multiorgan failure, we changed our strategy in favor of HTx in VAD patients in stable hemodynamic condition, with normal organ function and preferably discharged home. These patients are on the normal waiting list and acquire high-urgency status only if VAD complications occur.…”